Other candidates include BRINP1 (silenced in some bladder cancers), CD7 (associated with leukaemia), CSTA (encodes a stefin that functions as a cysteine protease inhibitor, suggested as a prognostic tool for cancer), and SUPT20H (a known tumour rejection antigen). Here, BRINP1 is linked to leukemia.